- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Actinogen Medical Ltd (ACW)
The Actinogen Medical share price today is 0.044 %REPORT_CURRENCY%, view ASX ACW stock exchange data. Track the latest Actinogen Medical share price with real-time updates on ACW stock performance including market cap, day range, 52-week range and dividend yield. Access ACW charts, earnings dates and analyst estimates to support your investment decisions.
Sydney
Currency in AUD
0.044
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.044
0.046
52 wk Range
0.019
0.072
ACW is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0440.046
52 wk Range
0.0190.072
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ACW Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
0.080
Upside
+81.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer’s disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Compare ACW to Peers and Sector
Metrics to compare | ACW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACWPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.8x | −6.4x | −0.5x | |
PEG Ratio | 0.16 | −0.05 | 0.00 | |
Price/Book | 18.9x | 3.3x | 2.6x | |
Price / LTM Sales | 21.5x | 16.9x | 3.2x | |
Upside (Analyst Target) | 81.8% | 159.1% | 47.4% | |
Fair Value Upside | Unlock | −0.3% | 7.7% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.080
(+81.82% Upside)
Earnings
Latest Release
25-02-2026
EPS / Forecast
-- / --
Revenue / Forecast
1.87M / --
FAQ
What Is the Actinogen Medical (ACW) Share Price Today?
The Actinogen Medical share price today is 0.044 AUD.
What is the current Actinogen Medical (ACW) share price and day range?
As of 25-04-2026, the Actinogen Medical share price is 0.044 AUD, with a previous close of 0.044 AUD. The share price has ranged from 0.044 to 0.046 AUD today, while the 52-week range spans from 0.019 to 0.072 AUD.
What Is the Actinogen Medical Market Cap?
As of today, Actinogen Medical market cap is 158.030M.
What Is the Actinogen Medical (ACW) Share Price Target?
The average 12-month share price target for Actinogen Medical is 0.080 AUD, with a high estimate of 0.08 AUD and a low estimate of 0.08 AUD. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +81.82% Upside potential.
What Is Actinogen Medical's Earnings Per Share (TTM)?
The Actinogen Medical EPS (TTM) is -0.006.
When Is the Next Actinogen Medical Earnings Date?
Actinogen Medical will release its next earnings report on 03-06-2026.
From a Technical Analysis Perspective, Is ACW a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Actinogen Medical Trade On?
Actinogen Medical is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Actinogen Medical?
The stock symbol for Actinogen Medical is "ACW."
How Many Times Has Actinogen Medical Stock Split?
Actinogen Medical has split 4 times.
How Many Employees Does Actinogen Medical Have?
Actinogen Medical has 6 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.